On August 9, 2018, the Supreme Court of Canada denied Sobeys’ application for leave to appeal (docket no. 37864) from the Alberta Court of Appeal (ABCA)’s decision in a dispute regarding the Alberta College of Pharmacists (the “College”)’s policy prohibiting pharmacists/pharmacies from offering loyalty rewards programs or inducements to patients.
The ABCA held that the policy was intra vires the College under the Health Professions Act and reasonable (Alberta College of Pharmacists v Sobeys West Inc., 2017 ABCA 306), disagreeing with the application judge regarding the appropriate standard of review and on the merits (Sobeys West Inc. v Alberta College of Pharmacists, 2016 ABQB 138; Sobeys West Inc. v Alberta College of Pharmacists, 2016 ABQB 232).
This decision follows the Supreme Court’s 2016 refusal to grant Sobeys leave to appeal a British Columbia Court of Appeal decision allowing the College of Pharmacists of British Columbia to prohibit “customer incentive programs”: Sobeys West Inc. v College of Pharmacists of British Columbia, 2016 BCCA 41; SCC docket no. 36917.
Related Publications & Articles
-
FCA sets aside PMPRB’s order that Galderma’s patent claiming 0.3% adapalene “pertained to” 0.1% adapalene DIFFERIN
On December 3, 2024, the Federal Court of Appeal (FCA) set aside the order of the Patented Medicine Prices Review Board (PMPRB or Board) that had required Galderma to continue to provide information t...Read More -
Class actions relating to opioid use disorder continue across Canada
There are multiple ongoing class actions in Canada against pharmaceutical companies related to Opioid Use Disorder (OUD) and its effects.Read More -
Federal Court finds patent ineligible for listing against SNDS
In Bayer Inc v Amgen Canada Inc, 2024 FC 1849, the Court granted a motion brought by Amgen for a declaration that Canadian Patent No. 3,007,276 (276 patent) was ineligible for inclusion on the Patent ...Read More